338 related articles for article (PubMed ID: 18980540)
21. Progress in introduction of pneumococcal conjugate vaccine--worldwide, 2000-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Oct; 57(42):1148-51. PubMed ID: 18946462
[TBL] [Abstract][Full Text] [Related]
22. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
[TBL] [Abstract][Full Text] [Related]
23. Pneumococcal conjugate vaccines. A review.
Galiza EP; Heath PT
Minerva Med; 2007 Apr; 98(2):131-43. PubMed ID: 17519855
[TBL] [Abstract][Full Text] [Related]
24. Pneumococcal vaccines for children: a global public health priority.
Pittet LF; Posfay-Barbe KM
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():25-36. PubMed ID: 22862432
[TBL] [Abstract][Full Text] [Related]
25. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
[TBL] [Abstract][Full Text] [Related]
26. Estimated effect of pneumococcal conjugate vaccination on invasive pneumococcal disease and associated mortality, Denmark 2000-2005.
Harboe ZB; Valentiner-Branth P; Benfield TL; Christensen JJ; Hjuler T; Kaltoft M; Krogfelt KA; Lambertsen L; Konradsen HB
Vaccine; 2008 Jul; 26(29-30):3765-71. PubMed ID: 18513840
[TBL] [Abstract][Full Text] [Related]
27. [Pneumococcal vaccination: conjugated vaccine induces herd immunity and reduces antibiotic resistance].
Pletz MW; Maus U; Hohlfeld JM; Lode H; Welte T
Dtsch Med Wochenschr; 2008 Feb; 133(8):358-62. PubMed ID: 18270917
[TBL] [Abstract][Full Text] [Related]
28. Genetic characteristics of pneumococcal disease in elderly patients before introducing the pneumococcal conjugate vaccine.
Pichon B; Bennett HV; Efstratiou A; Slack MP; George RC
Epidemiol Infect; 2009 Jul; 137(7):1049-56. PubMed ID: 19161642
[TBL] [Abstract][Full Text] [Related]
29. Impact of the 10-valent pneumococcal non-typeable Haemophilus influenzae Protein D conjugate vaccine (PHiD-CV) on bacterial nasopharyngeal carriage.
Prymula R; Hanovcova I; Splino M; Kriz P; Motlova J; Lebedova V; Lommel P; Kaliskova E; Pascal T; Borys D; Schuerman L
Vaccine; 2011 Feb; 29(10):1959-67. PubMed ID: 21215830
[TBL] [Abstract][Full Text] [Related]
30. Pneumococcal vaccines: an update on current strategies.
Bogaert D; Hermans PW; Adrian PV; Rümke HC; de Groot R
Vaccine; 2004 Jun; 22(17-18):2209-20. PubMed ID: 15149779
[TBL] [Abstract][Full Text] [Related]
31. [Present view of conjugated pneumococcus vaccines].
Prymula R
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):98-102. PubMed ID: 17051470
[TBL] [Abstract][Full Text] [Related]
32. Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries.
Talbird SE; Taylor TN; Knoll S; Frostad CR; García Martí S
Vaccine; 2010 Nov; 28 Suppl 6():G23-9. PubMed ID: 21075266
[TBL] [Abstract][Full Text] [Related]
33. The safety of 7-valent pneumococcal conjugate vaccine.
Ghaffar F
Expert Opin Drug Saf; 2005 Jul; 4(4):631-6. PubMed ID: 16011442
[TBL] [Abstract][Full Text] [Related]
34. Current status of pneumococcal vaccines: lessons to be learned and new insights.
Dinleyici EC
Expert Rev Vaccines; 2010 Sep; 9(9):1017-22. PubMed ID: 20822344
[TBL] [Abstract][Full Text] [Related]
35. Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.
Temime L; Boelle PY; Opatowski L; Guillemot D
PLoS One; 2008 Sep; 3(9):e3244. PubMed ID: 18802466
[TBL] [Abstract][Full Text] [Related]
36. Prevention of pneumococcal disease through vaccination.
Gentile A; Bazán V
Vaccine; 2011 Sep; 29 Suppl 3():C15-25. PubMed ID: 21896348
[TBL] [Abstract][Full Text] [Related]
37. Understanding the link between pneumococcal serotypes and invasive disease.
Soley C; Arguedas A
Vaccine; 2009 Aug; 27 Suppl 3():C19-21. PubMed ID: 19535183
[TBL] [Abstract][Full Text] [Related]
38. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
[TBL] [Abstract][Full Text] [Related]
40. [Pneumococcal vaccine: protection of adults and reduction of antibiotic resistence by vaccination of children with a conjugated vaccine].
Pletz MW
Med Monatsschr Pharm; 2011 Jun; 34(6):201-5. PubMed ID: 21812250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
